Stem cell therapy for myocardial regeneration: The Chinese experience

Stem Cell Bioengineering and Tissue Engineering Microenvironment

Volumn , Issue , 2011, Pages 457-480

  Kao, Race L ^a   Ha, Tuanzhu ^a   Li, Chuanfu ^a   Gao, Xiang ^b   Zhang, Fumin ^c   Yiang, Zhijian ^c   Chen, Yijiang ^c   Ma, Wenzhu ^c  

^a East Tennessee State University   (United States)

^b NANJING UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CYTOLOGY; HEART; NEURONS; PATIENT REHABILITATION; PATIENT TREATMENT;

ACUTE MYOCARDIAL INFARCTION; BONE MARROW CELLS; CORONARY ARTERY BYPASS GRAFT; EXPONENTIAL INCREASE; LEFT VENTRICULAR EJECTION FRACTION; PERCUTANEOUS CORONARY INTERVENTION; STEM CELL RESEARCH; STEM CELL THERAPY;

STEM CELLS;

EID: 84891747701     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812837899_0016     Document Type: Chapter

References (84)

1. Nussbaum J, Minami E, Laflamme MA, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J2007;21:1345-1357.
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell2006;126:663-676.
3. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell2007; 131:861-872.
4. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature2007;448:318-324.
5. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol2007;25:1177-1181.
6. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science2007;318:1917-1920.
7. Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science2008;321:699-702.
8. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in prosurvival factors enhance function of infarcted rat hearts. Nat Biotechnol2007;25:1015-1024.
9. Yao S, Chen S, Clark J, et al. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci USA2006;103:6907-6912.
10. Wagers AJ, Weissman IL. Plasticity of adult stem cells.Cell2004;116:639-648.
11. Lakshmipathy U, Verfaillie C. Stem cell plasticity. Blood Rev2005;19:29-38.
12. Vieyra DS, Jackson KA, Goodell MA. Plasticity and tissue regenerative potential of bone marrow-derived cells. Stem Cell Rev2005;1:65-69.
13. Warburton D, Koh C, Chung HM, et al. Meeting report: the first international collaborative symposium on stem cell research, Seoul Korea. Stem Cells2007;25:1337-1338.
14. Singec I, Jandial R, Crain A, et al. The leading edge of stem cell therapeutics. Ann Rev Med2007;58:313-328.
15. Burt RK, Loh Y, Pearce W, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA2008;299:925-936.
16. Jawad H, Ali NN, Lyon AR, et al. Myocardial tissue engineering: a review. J Tissue Eng Regen Med2007;1:327-342.
17. Wu KH, Mo XM, Liu YL, et al. Stem cells for tissue engineering of myocardial constructs. Aging Res Rev2007;6:289-301.
18. Giraud MN, Armbruster C, Carrel T, Tevaearai HT. Current state of the art in myocardial tissue engineering. Tissue Eng2007;13:1825-1836.
19. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg1995;60:12-18.
20. Kao RL, Chua R-J. (eds.). Cellular Cardiomyoplasty: Myocardial Repair with Cell Implantation.Landes, Austin, TX, 1997.
21. Kao RL. Transplantation of satellite cells for myocardial regeneration. In: Handbook of Cardiovascular Cell Transplantation,1st Edn. (eds.) Kipshidae NN, Serruys PW. Martin Dunitz, London, England, 2004, pp. 91-105.
22. Kao RL, Ganote CE, Pennington DG, Browder IW. Myocardial regeneration, tissue engineering and therapy. In: Artificial Cells, Cell Engineering and Therapy,1st Edn. (ed.) Prakash S. Woodhead Publishing Ltd., Cambridge, England, 2007, pp. 349-365.
23. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med1998;4:929-933.
24. Hagège AA, Marolleau JP, Vilquin JT, et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation2006;114(Suppl I):108-113.
25. Prockop DJ, Olson SD. Clinical trials with adult stem/progenitor cells for tissue repair: let’s not overlook some essential precautions. Blood2007;109:3147-3151.
26. McMullen NM, Pasumarthi KB. Donor cell transplantation for myocardial disease: does it complement current pharmacological therapies?Can J Physiol Pharmacol2007;85:1-15.
27. Dib N, Michler RE, Pagani FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: 4-year follow-up. Circulation2005;112:1748-1755.
28. Menasché P, Alfieri O, Janssens S, et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebocontrolled study of myoblast transplantation. Circulation2008;117:1189-1200.
29. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation1999;100(Suppl II):247-256.
30. Wang JS, Shum-Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg2000;120:999-1005.
31. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature2001;410:701-705.
32. Christoforou N, Gearhart JD. Stem cells and their potential in cell-based cardiac therapies. Prog Cardiovasc Dis2007;49:396-413.
33. Leri A, Kajstura J, Anversa P, Frishman WH. Myocardial regeneration and stem cell repair. Curr Probl Cardiol2008;33:91-153.
34. Luo J, Chiu RCJ, Tim-Shum D. Bone marrow stromal cells as “universal donor cells” for myocardial regeneration therapy. In: Artificial Cells, Cell Engineering and Therapy(ed.) Prakash S. Woodhead Publishing Ltd., Cambridge, England, 2007, pp. 333-348.
35. Jolicoeur EM, Granger CB, Fakunding JL, et al. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood institute Cell Therapy Working Group meeting. Am Heart J2007;153:732-742.
36. Schuleri KH, Boyle AJ, Hare JM. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol2007;180:195-218.
37. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature2008;451:937-942.
38. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol2004;44:1690-1699.
39. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol2005;46:1651-1658.
40. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.Circulation2006; 113:1287-1294.
41. Kang HJ, Lee HY, Na SH, et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation2006;114(Suppl I):145-151.
42. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med2006;355:1199-1209.
43. Meluzin J, Mayer J, Groch L, et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J2006;152:975-975.
44. Lunde K, Solheim S, Aakhus S, et al. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J2007;154:710-710.
45. Erbs S, Linke A, Adams V, et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res2005;97:756-762.
46. Janssens S, Dubois C, Bogaert J, et al.Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet2006;367:113-121.
47. Schächinger V, Erbs S, Elsässer A, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final one-year results of the REPAIR-AMI trial. Eur Heart J2006;27:2775-2783.
48. Assmus B, Honold J, Schächinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med2006;355:1222-1232.
49. Liao L, Li L, Zhao RC. Stem cell research in China.Philos Trans R Soc Lond B Biol Sci2007;362:1107-1112.
50. Liao L, Zhao RC. An overview of stem cell-based clinical trials in China. Stem Cells Dev2008;17:613-618.
51. Zhang F, Gao X, Yiang ZJ, et al. Cellular cardiomyoplasty: a preliminary clinical report. Cardiovasc Radiat Med2003;4:39-42.
52. Zhang F, Yang Z, Chen Y, et al. Clinical cellular cardiomyoplasty: technical considerations. J Card Surg2003;18:268-273.
53. Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol2004;94:92-95.
54. Gao LR, Wang ZG, Zhu ZM, et al. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy. Am J Cardiol2006;98:597-602.
55. Ge J, Li Y, Qian J, et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart2006;92:1764-1767.
56. Yao K, Huang R, Qian J, et al. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart2008;94:1147-1153.
57. Li ZQ, Zhang M, Jing YZ, et al. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Int J Cardiol2007;115:52-56.
58. Agbulut O, Vandervelde S, AlAttar N, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol2004;44:458-463.
59. Guarita-Souza LC, Carvalho KA, Rebelatto C, et al. Cell transplantation: differential effects of myoblasts and mesenchymal stem cells. Int J Cardiol2006;111:423-429.
60. Thompson RB, Emani SM, Davis BH, et al. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. Circulation2003;108(Suppl II):264-271.
61. Ye L, Haider HKH, Sim EK. Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells. Exp Biol Med (Maywood)2006;231:8-19.
62. Seeger FH, Tonn T, Krzossok N. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J2007;28:766-772.
63. Hristov M, Heussen N, Schober A, Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med2006; 10:727-733.
64. Lipinski MJ, Biondi-Zoccai GG Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007;50:1761-1767.
65. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med2007;167:989-997.
66. Bartunek J, Dimmeler S, Drexler H, et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J2006;27:1338-1340.
67. Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol2008;28:208-216.
68. Muller-Ehmsen J, Krausgrill B, Burst V, et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol2006;41:876-884.
69. Al Kindi A, Ge Y, Shum-Tim D, Chiu RC. Cellular cardiomyoplasty: routes of cell delivery and retention. Front Biosci2008;13:2421-2434.
70. Anderl JN, Robey TE, Stayton PS, Murry CE. Retention and biodistribution of microspheres injected into ischemic myocardium. J Biomed Mater Res A2009;88:704-710.
71. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol2005;23:845-856.
72. Frangogiannis NG. The mechanistic basis of infarct healing. Antioxid Redox Signal2006;8:1907-1939.
73. Frantz S, Bauersachs J, Kelly RA. Innate immunity and the heart. Curr Pharm Des2005;11:1279-1290.
74. Linde A, Mosier D, Blecha F, Melgarejo T. Innate immunity and inflammation - New frontiers in comparative cardiovascular pathology. Cardiovasc Res2007;73:26-36.
75. Baumgarten G, Kim SC, Stapel H, et al. Myocardial injury modulates the innate immune system and changes myocardial sensitivity. Basic Res Cardiol2006;101:427-435.
76. Kapadia S, Dibbs Z, Kurrelmeyer K, et al. The role of cytokines in the failing human heart. Cardiol Clin1998;16:645-656.
77. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation1997;95:778-781.
78. Ono K, Matsumori A, Shioi T. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation1998;98:148-156.
79. Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?Trends Immunol2007;28:219-226.
80. Stagg J. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens2007;69:1-9.
81. Solheim S, Seljeflot I, Lunde K, et al. Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction. Am Heart J2008;155:55
82. Thum T, Bauersachs J, Poole-Wilson PA, et al. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol2005;46:1799-802.
83. Tomchuck SL, Zwezdaryk KJ, Coffelt SB, et al. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulat-ing responses. Stem Cells2008;26:99-107.
84. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res2006;312:2169-79.